Vrati se na sadržaj

Ortopedska hirurgija

Ekonomski rezultati

Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). (otvara novi prozor)

Freedman J, Luke K, Escobar M, Vernich L, Chiavetta JA.

Izvor‎: Transfusion 2008;48(2):237-50.

Indeks‎: PubMed 18005329

DOI‎: 10.1111/j.1537-2995.2007.01515.x

https://www.ncbi.nlm.nih.gov/pubmed/18005329 (otvara novi prozor)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (otvara novi prozor)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Izvor‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Indeks‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (otvara novi prozor)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (otvara novi prozor)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Izvor‎: Int Orthop 2019;43(12):2707-14.

Indeks‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (otvara novi prozor)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (otvara novi prozor)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Izvor‎: J Arthroplasty 2014;29(8):1512-5.

Indeks‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (otvara novi prozor)